Canada
· Delayed Price · Currency is CAD MedMira Statistics
Total Valuation
MedMira has a market cap or net worth of CAD 57.66 million. The enterprise value is 71.12 million.
| Market Cap | 57.66M |
| Enterprise Value | 71.12M |
Important Dates
The last earnings date was Thursday, November 28, 2024.
| Earnings Date | Nov 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MedMira has 720.81 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 720.81M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | n/a |
| Float | 223.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 135.82 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.38 |
| EV / Sales | 172.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.32 |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.23 |
| Interest Coverage | -2.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.08% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 7,934 |
| Profits Per Employee | -63,968 |
| Employee Count | 52 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 5.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.11% in the last 52 weeks. The beta is 10.66, so MedMira's price volatility has been higher than the market average.
| Beta (5Y) | 10.66 |
| 52-Week Price Change | -11.11% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 47.45 |
| Average Volume (20 Days) | 47,877 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedMira had revenue of CAD 412,568 and -3.33 million in losses. Loss per share was -0.00.
| Revenue | 412,568 |
| Gross Profit | -616,624 |
| Operating Income | -2.57M |
| Pretax Income | -3.33M |
| Net Income | -3.33M |
| EBITDA | -2.53M |
| EBIT | -2.57M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 2.10 million in cash and 15.55 million in debt, giving a net cash position of -13.46 million or -0.02 per share.
| Cash & Cash Equivalents | 2.10M |
| Total Debt | 15.55M |
| Net Cash | -13.46M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -18.04M |
| Book Value Per Share | -0.03 |
| Working Capital | -17.28M |
Cash Flow
In the last 12 months, operating cash flow was -2.94 million and capital expenditures -742,535, giving a free cash flow of -3.68 million.
| Operating Cash Flow | -2.94M |
| Capital Expenditures | -742,535 |
| Free Cash Flow | -3.68M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | -149.46% |
| Operating Margin | -623.65% |
| Pretax Margin | -806.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -892.23% |
Dividends & Yields
MedMira does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -6.25% |
| FCF Yield | -6.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedMira has an Altman Z-Score of -26.52. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.52 |
| Piotroski F-Score | n/a |